Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice.


Journal

American journal of respiratory and critical care medicine
ISSN: 1535-4970
Titre abrégé: Am J Respir Crit Care Med
Pays: United States
ID NLM: 9421642

Informations de publication

Date de publication:
01 05 2023
Historique:
medline: 3 5 2023
pubmed: 27 1 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

Patients with chronic obstructive pulmonary disease (COPD) may suffer from acute episodes of worsening dyspnea, often associated with increased cough, sputum, and/or sputum purulence. These exacerbations of COPD (ECOPDs) impact health status, accelerate lung function decline, and increase the risk of hospitalization. Importantly, close to 20% of patients are readmitted within 30 days after hospital discharge, with great cost to the person and society. Approximately 25% and 65% of patients hospitalized for an ECOPD die within 1 and 5 years, respectively. Patients with COPD are usually older and frequently have concomitant chronic diseases, including heart failure, coronary artery disease, arrhythmias, interstitial lung diseases, bronchiectasis, asthma, anxiety, and depression, and are also at increased risk of developing pneumonia, pulmonary embolism, and pneumothorax. All of these morbidities not only increase the risk of subsequent ECOPDs but can also mimic or aggravate them. Importantly, close to 70% of readmissions after an ECOPD hospitalization result from decompensation of other morbidities. These observations suggest that in patients with COPD with worsening dyspnea but without the other classic characteristics of ECOPD, a careful search for these morbidities can help detect them and allow appropriate treatment. For most morbidities, a thorough clinical evaluation supplemented by appropriate clinical investigations can guide the healthcare provider to make a precise diagnosis. This perspective integrates the currently dispersed information available and provides a practical approach to patients with COPD complaining of worsening respiratory symptoms, particularly dyspnea. A systematic approach should help improve outcomes and the personal and societal cost of ECOPDs.

Identifiants

pubmed: 36701677
doi: 10.1164/rccm.202209-1795CI
pmc: PMC10161746
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1134-1144

Subventions

Organisme : Medical Research Council
ID : G0800570
Pays : United Kingdom

Références

JAMA. 2019 Feb 26;321(8):786-797
pubmed: 30806700
Chest. 2010 May;137(5):1091-7
pubmed: 20022970
N Engl J Med. 2019 Sep 26;381(13):1257-1266
pubmed: 31553837
JAMA. 2009 Sep 9;302(10):1059-66
pubmed: 19738090
Chest. 2008 May;133(5):1088-94
pubmed: 18339792
J Thorac Cardiovasc Surg. 2009 Jul;138(1):192-5
pubmed: 19577078
Am J Respir Crit Care Med. 2016 Sep 1;194(5):568-76
pubmed: 27442601
BMC Pulm Med. 2017 Jan 10;17(1):11
pubmed: 28073350
Circulation. 2022 May 3;145(18):e895-e1032
pubmed: 35363499
Am J Respir Crit Care Med. 2012 Jul 15;186(2):155-61
pubmed: 22561964
Ann Am Thorac Soc. 2022 Jan;19(1):143-146
pubmed: 34343034
Ann Am Thorac Soc. 2018 Jun;15(6):710-717
pubmed: 30726108
Ann Intern Med. 2021 Jun;174(6):HO2-HO3
pubmed: 34126023
Ann Am Thorac Soc. 2022 Jul;19(7):1102-1111
pubmed: 35007497
Respir Res. 2020 Jun 30;21(1):164
pubmed: 32605574
JAMA. 2021 Jan 05;325(1):59-68
pubmed: 33399840
Chest. 2017 Jun;151(6):1295-1301
pubmed: 28212836
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
ESC Heart Fail. 2022 Aug;9(4):2500-2510
pubmed: 35561100
Circulation. 2018 Nov 13;138(20):e618-e651
pubmed: 30571511
Chest. 2011 Mar;139(3):505-512
pubmed: 20576732
J Thorac Dis. 2017 Mar;9(3):636-645
pubmed: 28449471
Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75
pubmed: 27299520
Am J Respir Crit Care Med. 2016 Dec 1;194(11):1319-1336
pubmed: 27589227
N Engl J Med. 2018 Feb 22;378(8):740-751
pubmed: 29466146
Am J Respir Crit Care Med. 2016 Feb 1;193(3):299-309
pubmed: 26407036
Eur Respir J. 2017 Sep 9;50(3):
pubmed: 28889110
Int J Chron Obstruct Pulmon Dis. 2017 May 11;12:1401-1411
pubmed: 28546748
Heart Lung. 2022 Jan-Feb;51:67-74
pubmed: 34740082
Respirology. 2020 Aug;25(8):836-849
pubmed: 32064708
Int J Chron Obstruct Pulmon Dis. 2018 Jan 08;13:217-229
pubmed: 29386890
Eur J Emerg Med. 2018 Feb;25(1):3-11
pubmed: 29252938
Eur J Intern Med. 2011 Feb;22(1):103-7
pubmed: 21238904
Eur Respir J. 2022 May 19;59(5):
pubmed: 35273031
J Infect. 2022 Dec;85(6):625-633
pubmed: 36096312
Clin Microbiol Infect. 2011 Nov;17 Suppl 6:E1-59
pubmed: 21951385
Ann Am Thorac Soc. 2018 Jul;15(7):837-845
pubmed: 29611719
Medicine (Baltimore). 2017 May;96(19):e6917
pubmed: 28489809
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465817750524
pubmed: 29355081
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
Lancet Respir Med. 2015 Aug;3(8):631-9
pubmed: 26208998
J Psychopharmacol. 2014 May;28(5):449-56
pubmed: 24646808
Eur Respir J. 2008 Jul;32(1):53-60
pubmed: 18321938
PLoS One. 2016 Mar 15;11(3):e0150532
pubmed: 26978269
Thorax. 2015 Oct;70(10):984-9
pubmed: 26219979
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1251-1258
pubmed: 34570991
Respir Med Res. 2022 May;81:100892
pubmed: 35489109
Circulation. 2017 May 30;135(22):e1054-e1091
pubmed: 28446515
JAMA. 2021 Oct 5;326(13):1277-1285
pubmed: 34609451
Card Fail Rev. 2015 Oct;1(2):69-74
pubmed: 28785435
Semin Respir Crit Care Med. 2020 Dec;41(6):817-829
pubmed: 32726837
N Engl J Med. 2022 Jul 7;387(1):45-57
pubmed: 35793208
Eur Respir J. 2019 Sep 19;54(3):
pubmed: 31248958
Int J Chron Obstruct Pulmon Dis. 2014 Mar 29;9:315-30
pubmed: 24729698
Heart. 2015 Jul;101(14):1103-10
pubmed: 25765553
Eur Respir J. 2012 Dec;40(6):1344-53
pubmed: 22523352
Ann Intern Med. 1998 Dec 15;129(12):1044-9
pubmed: 9867760
Ann Thorac Med. 2019 Jul-Sep;14(3):165-172
pubmed: 31333765
N Engl J Med. 2011 Mar 10;364(10):897-906
pubmed: 21388308
Am J Respir Crit Care Med. 2018 Jul 1;198(1):51-57
pubmed: 29442524
Am J Respir Crit Care Med. 1996 Jul;154(1):6-17
pubmed: 8680700
Eur Respir J. 2020 May 14;55(5):
pubmed: 32079642
Chest. 2017 Mar;151(3):544-554
pubmed: 27522956
Am J Respir Crit Care Med. 2013 Nov 1;188(9):1091-9
pubmed: 24033321
Respir Med Case Rep. 2020 Mar 27;30:101044
pubmed: 32257794
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1130-1139
pubmed: 29979608
Respirology. 2021 Jun;26(6):532-551
pubmed: 33893708
Curr Opin Pulm Med. 2012 Sep;18(5):418-27
pubmed: 22781207
ERJ Open Res. 2021 Nov 22;7(4):
pubmed: 34820447
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36
pubmed: 33146552
Chest. 2011 Jun;139(6):1410-1418
pubmed: 21030489
Lancet Respir Med. 2018 Sep;6(9):657-659
pubmed: 30029970
Card Fail Rev. 2017 Apr;3(1):56-61
pubmed: 28785477

Auteurs

Bartolome R Celli (BR)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Leonardo M Fabbri (LM)

Section of Respiratory Medicine, Department of Translational Medicine, and.

Shawn D Aaron (SD)

The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Alvar Agusti (A)

Universitat de Barcelona, Barcelona, Spain.
Institut Clínic Respiratori, Hospital Clínic de Barcelona, Barcelona, Spain.
Instituto de Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain.
Centro de Investigación Biomédica en Red Enfermedades Respiratorias, Madrid, Spain.

Robert D Brook (RD)

Division of Cardiovascular Medicine, Department of Internal Medicine, Wayne State University, Detroit, Michigan.

Gerard J Criner (GJ)

Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.

Frits M E Franssen (FME)

Department of Research and Education, CIRO, Horn, the Netherlands.
Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.

Marc Humbert (M)

Department of Respiratory and Intensive Care Medicine, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Université Paris-Saclay and Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 999, Le Kremlin-Bicêtre, France.

John R Hurst (JR)

UCL Respiratory, University College London, London, United Kingdom.

Maria Montes de Oca (M)

Universidad Central de Venezuela, School of Medicine, Centro Medico de Caracas, Caracas, Venezuela.

Leonardo Pantoni (L)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Alberto Papi (A)

Section of Respiratory Medicine, University of Ferrara, Ferrara, Italy.
Emergency Department, St. Anna University Hospital, Ferrara, Italy.

Roberto Rodriguez-Roisin (R)

Universitat de Barcelona, Barcelona, Spain.
Institut Clínic Respiratori, Hospital Clínic de Barcelona, Barcelona, Spain.

Sanjay Sethi (S)

Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York.

Daiana Stolz (D)

Clinic of Respiratory Medicine and Pulmonary Cell Research and.
Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Clinic of Respiratory Medicine and Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Antoni Torres (A)

Universitat de Barcelona, Barcelona, Spain.
Institut Clínic Respiratori, Hospital Clínic de Barcelona, Barcelona, Spain.
Instituto de Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats Acadèmia, Centre d'Investigació Biomèdica en Xarxa de Malalties Respiratòries, Barcelona, Spain.

Claus F Vogelmeier (CF)

Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Centre Giessen and Marburg, Philipps University of Marburg, Member of the German Centre for Lung Research (DZL), Marburg, Germany; and.

Jadwiga A Wedzicha (JA)

Respiratory Division, National Heart and Lung Institute, Imperial College, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH